Security Risk Assessment Checklist for Eye Banks and Cornea Registries

Define Scope of Protected Health Information

You start by pinpointing exactly which Protected Health Information (PHI) you create, receive, store, and transmit. In eye banks and cornea registries, PHI spans donor, recipient, and operational data linked to individuals, both on paper and in electronic systems (ePHI).

Identify PHI/ePHI unique to eye banking

• Donor records: medical–social history, consent and authorization forms, infectious disease testing results, serology, adverse findings, and Donor Eligibility Assessment outcomes.
• Clinical artifacts: corneal evaluation reports, slit-lamp photos, specular microscopy images, and surgeon feedback tied to a recipient.
• Recipient and allocation data: identifiers, indications, scheduling notes, outcomes, and communications with transplant centers.
• Operational metadata: Tissue Traceability identifiers (for example, standardized donation identification numbers), chain-of-custody logs, shipping details, and storage conditions when linked to a person.

Map data flows and boundaries

• Sources: hospitals, organ procurement organizations, labs, pathology, and surgeon offices.
• Repositories: eye bank management systems, cornea registries, email, secure messaging tools, file shares, cloud apps, mobile devices, and paper files.
• Destinations: surgeons and transplant centers, auditors, regulators, and accreditation bodies.
• Classify data: PHI/ePHI, de-identified data, and limited data sets; define retention and archival locations.

Inventory systems and third parties

• Catalog applications, databases, instruments that generate data, and labeling systems used for Tissue Traceability.
• List business associates and vendors that handle PHI; note contracts, encryption expectations, and data return/destruction terms.

Assign Leadership and Accountability

Clear ownership drives effective security. Assign named leaders and document responsibilities so decisions are timely and auditable.

Define core roles

• Executive sponsor to set priorities and approve funding.
• Security Officer to run the Security Risk Analysis, maintain the risk register, and oversee safeguards.
• Privacy Officer to enforce minimum necessary use, access approvals, and breach notification.
• Quality/Compliance lead to align with accreditation and Tissue Traceability requirements.
• IT lead to operate technical controls, backups, and incident response tooling.
• Data stewards for donor, recipient, and registry datasets to validate data quality and access rights.

Establish decision rights and cadence

• Use a simple RACI for policy approvals, access provisioning, vendor onboarding, and incident escalation.
• Hold quarterly reviews of risks, audit findings, training completion, and open corrective actions.

Perform Risk Analysis

Conduct a formal Security Risk Analysis tailored to eye bank and registry workflows. Evaluate confidentiality, integrity, and availability risks for each asset, process, and data flow you inventoried.

Step-by-step approach

• Identify assets: PHI datasets, registry databases, labeling and tracking tools, email, endpoints, and facilities.
• Enumerate threats and vulnerabilities: phishing, ransomware, misdirected email, lost devices, weak access reviews, mislabeling that breaks Tissue Traceability, and vendor outages.
• Score likelihood and impact (e.g., 1–5 scale) and compute risk ratings; document assumptions and existing controls.
• Record results in a risk register; decide to mitigate, transfer, accept, or avoid each risk, with owners and due dates.

High-impact scenarios to evaluate

• Unauthorized access to donor serology and Donor Eligibility Assessment files.
• Compromise of the eye bank management system or cornea registry, disrupting scheduling and allocation.
• Breaks in chain-of-custody logs that impair Tissue Traceability after a system outage.
• Misdirected PHI during surgeon communication or courier coordination.

Evidence to retain

• Scope statement, asset inventory, data-flow diagrams, methodologies used, and finalized risk register.
• Management sign-off on risk treatment plans and timelines.

Establish Policies and Procedures

Policies convert risk decisions into consistent practice. Keep them concise, role-based, and mapped to your safeguards and regulatory duties.

Core PHI policies

• Access control and least privilege, with identity proofing and periodic access recertification.
• Acceptable use, email and messaging with PHI, and secure remote access.
• Encryption standards for data in transit and at rest, including mobile devices and backups.
• Retention and secure destruction of donor, recipient, and registry records.
• Incident response and breach notification procedures with clear time frames.

Operational procedures specific to eye banks

• Donor Eligibility Assessment handling: confidentiality, segregation of sensitive testing, and dual review for eligibility status changes.
• Tissue Traceability: unique identifiers, label verification steps, chain-of-custody documentation, and reconciliation after downtime.
• Change control for systems that affect labeling, tracking, or data integrity in registries.

Vendor and business associate management

• Security requirements in contracts, right-to-audit clauses, breach reporting, data return, and destruction terms.
• Risk reviews for hosting providers, courier integrations, lab interfaces, and registry platforms.

Implement Security Safeguards

Deploy layered Administrative, Physical, and Technical Safeguards so one control failing does not cause a breach. Prioritize quick wins while planning strategic upgrades.

Administrative Safeguards

• Workforce security: background checks, confidentiality agreements, role-based training, and sanctions for noncompliance.
• Access management: joiner–mover–leaver workflows, quarterly access reviews, and emergency access procedures.
• Risk management: maintain the risk register, track remediation, and integrate with quality CAPA processes.
• Vendor oversight: security due diligence, Business Associate Agreements, and periodic attestations.

Physical Safeguards

• Controlled facility access, visitor logs, camera coverage in sensitive areas, and locked storage for paper PHI.
• Secure clean rooms and packaging areas; tamper-evident seals on containers with seal numbers recorded for Tissue Traceability.
• Device protections: cable locks, secure disposal, and media sanitization.
• Environmental monitoring with alarms for refrigerators/freezers and backup power to protect operations.

Technical Safeguards

• Authentication and authorization: unique IDs, MFA, role-based access, and session timeouts.
• Encryption: TLS for data in transit; strong encryption for data at rest on servers, endpoints, and backups.
• Endpoint and email security: anti-malware/EDR, phishing protection, and enforced email encryption for PHI.
• Network controls: segmentation of lab instruments and labeling systems, firewalls, and secure VPN.
• Audit controls: comprehensive logging, immutable logs for changes to eligibility status and traceability records, and regular log review.
• Resilience: 3-2-1 backups, offline/immutable copies, and tested restores aligned to defined RTO/RPO.

Monitor and Review Security Measures

Security is a continuous cycle. Measure performance, test controls, and adjust based on incidents, audits, and operational changes.

Continuous monitoring

• Automated alerts for suspicious logins, privilege changes, and large PHI exports.
• Configuration monitoring for registry databases and labeling systems that affect Tissue Traceability.

Audits and testing

• Periodic internal audits of access rights, label verification steps, and chain-of-custody completeness.
• Vulnerability scanning, targeted penetration tests of portals and interfaces, and simulated phishing campaigns.
• Downtime and restoration drills to validate data integrity and traceability after recovery.

Metrics and reporting

• Key indicators: time to disable terminated users, encryption coverage, backup success rate, and incident closure time.
• Quality-linked metrics: reconciliation accuracy for Tissue Traceability and on-time completion of Donor Eligibility Assessment reviews.

Corrective and preventive actions

• Root-cause analysis for incidents and near misses, with tracked CAPA and executive oversight.

Ensure Regulatory Compliance

Align your controls and documentation to applicable regulations and standards. Map each safeguard to requirements so auditors can trace evidence quickly.

Key obligations to address

• HIPAA Security and Privacy requirements for PHI, including Security Risk Analysis, minimum necessary, and breach notification.
• FDA requirements for human tissue establishments that impact labeling, records, and process controls related to Tissue Traceability.
• Accreditation standards for eye banks and cornea registries that define handling, documentation, and auditing expectations.
• State data protection and breach notification laws and, when applicable, international data transfer obligations.

Documentation and proof

• Maintain current policies, training logs, risk registers, vendor agreements, audit trails, and test results.
• Create a control matrix showing where Administrative, Physical, and Technical Safeguards satisfy each regulatory and accreditation clause.

Conclusion

A practical security risk assessment ties your PHI scope to real threats, prioritizes safeguards, and proves compliance. By assigning accountable leaders, performing a thorough Security Risk Analysis, enforcing clear procedures, and validating Tissue Traceability end to end, you protect donors and recipients while sustaining trustworthy eye bank and registry operations.

FAQs.

What are the key components of a security risk assessment for eye banks?

The core components are scoping PHI and data flows; assigning accountable leadership; conducting a structured Security Risk Analysis with documented risks and treatment plans; defining policies for access, incident response, retention, vendors, and traceability; implementing Administrative, Physical, and Technical Safeguards; and continuously monitoring, auditing, and improving controls.

How often should eye banks conduct security risk assessments?

Perform a comprehensive assessment at least annually and whenever major changes occur—such as new registry platforms, labeling systems, integrations, or facility moves. Run targeted reviews after incidents, system upgrades, or regulatory updates, and track remediation to closure.

What regulatory standards apply to security risk assessments in cornea registries?

Cornea registries should align with HIPAA Security and Privacy requirements for PHI, meet FDA expectations for records and process controls relevant to Tissue Traceability, and follow applicable accreditation standards for eye banks. State privacy and breach notification laws, and any cross-border data obligations, may also apply based on where data is collected and processed.